Metrics

From
Developing Potential Drugs for COVID-19 Using Ligand Based Virtual Screening by Kagia Richard American Journal of Pharmacological Sciences. 2020, 8(1), 9-13 doi:10.12691/ajps-8-1-3
Views
8546
Html 8280
Abstract 266
12 May 2020 (publication date) through 15 August 2026 *
19.56 % of article views led to PDF downloads *
*Although we update our data on a daily basis, there may be a 48-hour delay before the most recent numbers are available.
Downloads: 6289
PDF1672
Epub1362
XML1339
PPT0
Figures1449
Tables467
Export: 4086
RIS1255
BibTex1545
Endnote1286
RIS, BibTex, EndNote allows users to search, retrieve and store citations from bibliographic databases such as ABI Inform, the Web of Science, Anthropological Literature, the MLA bibliography, or the catalogs of individual libraries.
Area Chart Example: If your want to see the details of daily statistics for this article, please click here to login our Manuscript Tracking System.
Citations
0
Found additional citations for the article? Please contact us at submission@sciepub.com.
Shares & bookmarks
Facebook0
Twitter0
LinkedIn0
Google +0
Found additional shares or bookmarks for the article? Please contact us at submission@sciepub.com